LL64 57344 (Caffeine 200 mg)
Pill with imprint LL64 57344 is Yellow, Round and has been identified as Caffeine 200 mg. It is supplied by AAA Pharmaceutical, Inc..
Caffeine is used in the treatment of hypersomnia; apnea of prematurity; asthma and belongs to the drug class CNS stimulants. Caffeine Citrate Injection: Risk cannot be ruled out during pregnancy. Excluding Caffeine Citrate Injection: FDA has not classified the drug for risk during pregnancy. Caffeine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LL64 57344
Caffeine
- Imprint:
- LL64 57344
- Strength:
- 200 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out - Caffeine Citrate Injection
N - Not classified - excluding Caffeine Citrate Injection - CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- AAA Pharmaceutical, Inc.
- National Drug Code (NDC):
- 57344-0020
More about caffeine
- Caffeine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 20 Reviews
- Drug class: CNS stimulants
Consumer resources
- Caffeine Citrate
- Caffeine Capsules and Tablets
- Caffeine Oral Solution
- Caffeine (Advanced Reading)
- Caffeine citrate Intravenous (Advanced Reading)
Other brands: Vivarin, Lucidex, NoDoz, Cafcit, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
